RT @AkhmetzhanG: Congratulations! 👏👍 #machinelearning will be the future of medicine! @openscience @figshare @MaleLabTs @DeepMindAI @nresea…
Congratulations! 👏👍 #machinelearning will be the future of medicine! @openscience @figshare @MaleLabTs @DeepMindAI @nresearchnews @nature @ML_NLP !
RT @biogerontology: AI developed by @InSilicoMeds and @A_Aspuru_Guzik "imagined" new molecules that were synthesized, tested in human cel…
@kaifulee Original link 🙏 https://t.co/cyafxr1ZK5
A great pleasure to present @UChicagoMed . Amazing scientists!
RT @NvidiaAI: Congrats to #startup @inSilicoMeds for their work in #drugdiscovery, which demonstrates “the power of #AI, using a GAN approa…
Thank you @biogerontology for visiting us @UChicagoMed. Lots of collaborative ideas have evolved during your visit, which hopefully will result in more top notch publications like https://t.co/Gc1HFOgbr7 Looking forward to seeing you again at the Windy Cit
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @IraneusOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for phar…
RT @IraneusOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for phar…
RT @IraneusOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for phar…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
Alex Zhavoronkov, the author of this landmark paper and a frequent collaborator is presenting at our department @UChicagoMed today at 2PM. https://t.co/Gc1HFOgbr7
RT @IraneusOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for phar…
RT @IraneusOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for phar…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @Datascience__: Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/2zy78jKfeB #DeepLearning
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @biogerontology: Our paper surpassed 16K accesses at Nature Biotech. I wish I could make it Open Access https://t.co/cyafxr1ZK5
RT @NvidiaAI: Congrats to #startup @inSilicoMeds for their work in #drugdiscovery, which demonstrates “the power of #AI, using a GAN approa…
RT @IraneusOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for phar…
RT @jason_pontin: The publication of this paper by Alex Zhavoronkov et al was actually the most important thing that happened last week. (N…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @biogerontology: I will be presenting this paper at the @ACCP1_org in Chicago today. We can disrupt #ClinicalPharmacology if we find a w…
RT @pharmainturi: Deep learning enables rapid identification of potent DDR1 kinase inhibitors #insilico #insilicomedicine #ai #DDR1, #Natur…
Deep learning enables rapid identification of potent DDR1 kinase inhibitors #insilico #insilicomedicine #ai #DDR1, #Nature #insilicomeds, published in #NatureBiotech, #InsilicoAI @biogerontology https://t.co/ht4fTgoPMU
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
First big step towards treatment for human!
AI is helping for creating new drugs!
RT @IraneusOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for phar…
👍
Cool news!
RT @InSilicoMeds: Biggest News Today. Insilico Medicine's team made a breakthrough in AI for drug discovery last year. Today we are far ah…
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @NvidiaAI: Congrats to #startup @inSilicoMeds for their work in #drugdiscovery, which demonstrates “the power of #AI, using a GAN approa…
RT @NvidiaAI: Congrats to #startup @inSilicoMeds for their work in #drugdiscovery, which demonstrates “the power of #AI, using a GAN approa…
RT @IraneusOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for phar…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @Datascience__: Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/2zy78jKfeB #DeepLearning
Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/2zy78jKfeB #DeepLearning
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @IraneusOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for phar…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @FuturistAvenue: Science researchers successfully created a new medicine using AI, a new era of drug discovery rises soon 🌅 📰 Read on:…
RT @NvidiaAI: Congrats to #startup @inSilicoMeds for their work in #drugdiscovery, which demonstrates “the power of #AI, using a GAN approa…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @BenSingletonNYC: Deep learning enables rapid identification of potent DDR1 kinase inhibitors #DeepLearning #BigData https://t.co/9HbSbg…
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @IraneusOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for phar…
RT @IraneusOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for phar…
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @IraneusOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for phar…
RT @biogerontology: AI developed by @InSilicoMeds and @A_Aspuru_Guzik "imagined" new molecules that were synthesized, tested in human cel…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @NvidiaAI: Congrats to #startup @inSilicoMeds for their work in #drugdiscovery, which demonstrates “the power of #AI, using a GAN approa…
RT @NvidiaAI: Congrats to #startup @inSilicoMeds for their work in #drugdiscovery, which demonstrates “the power of #AI, using a GAN approa…
RT @BenSingletonNYC: Deep learning enables rapid identification of potent DDR1 kinase inhibitors #DeepLearning #BigData https://t.co/9HbSbg…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
Science researchers successfully created a new medicine using AI, a new era of drug discovery rises soon 🌅 📰 Read on: https://t.co/GTnY1NpHlQ 🔎 Published in Nature Biotechnology: https://t.co/grtHLvUDN2 #science 🏷 #ArtificialIntelligence 🏷 #biotech 🏷 #d
RT @NvidiaAI: Congrats to #startup @inSilicoMeds for their work in #drugdiscovery, which demonstrates “the power of #AI, using a GAN approa…
RT @NvidiaAI: Congrats to #startup @inSilicoMeds for their work in #drugdiscovery, which demonstrates “the power of #AI, using a GAN approa…
RT @InSilicoMeds: Biggest News Today. Insilico Medicine's team made a breakthrough in AI for drug discovery last year. Today we are far ah…
RT @NvidiaAI: Congrats to #startup @inSilicoMeds for their work in #drugdiscovery, which demonstrates “the power of #AI, using a GAN approa…
RT @NvidiaAI: Congrats to #startup @inSilicoMeds for their work in #drugdiscovery, which demonstrates “the power of #AI, using a GAN approa…
RT @NvidiaAI: Congrats to #startup @inSilicoMeds for their work in #drugdiscovery, which demonstrates “the power of #AI, using a GAN approa…
RT @InSilicoMeds: Biggest News Today. Insilico Medicine's team made a breakthrough in AI for drug discovery last year. Today we are far ah…
RT @NvidiaAI: Congrats to #startup @inSilicoMeds for their work in #drugdiscovery, which demonstrates “the power of #AI, using a GAN approa…
RT @NvidiaAI: Congrats to #startup @inSilicoMeds for their work in #drugdiscovery, which demonstrates “the power of #AI, using a GAN approa…
RT @NvidiaAI: Congrats to #startup @inSilicoMeds for their work in #drugdiscovery, which demonstrates “the power of #AI, using a GAN approa…
@NvidiaAI @InSilicoMeds @EricTopol Thank you! Can you please tweet the original link to the paper if possible? It is always better to link to original source. https://t.co/cyafxr1ZK5
RT @NvidiaAI: Congrats to #startup @inSilicoMeds for their work in #drugdiscovery, which demonstrates “the power of #AI, using a GAN approa…
RT @NvidiaAI: Congrats to #startup @inSilicoMeds for their work in #drugdiscovery, which demonstrates “the power of #AI, using a GAN approa…
RT @IraneusOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for phar…
Congrats to #startup @inSilicoMeds for their work in #drugdiscovery, which demonstrates “the power of #AI, using a GAN approach, to markedly accelerate the design & experimental validation of a new molecule, no less one targeting fibrosis, a major unme
RT @BenSingletonNYC: Deep learning enables rapid identification of potent DDR1 kinase inhibitors #DeepLearning #BigData https://t.co/9HbSbg…
RT @pasanOnline: GANs used for drug discovery. Pretty cool stuff. https://t.co/yEcFZjedpE
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @pasanOnline: GANs used for drug discovery. Pretty cool stuff. https://t.co/yEcFZjedpE
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…